RxDoctor Payments Data

Luigi Baretto, MD

Family Medicine · Ocean City, NJNPI 1619361011

Payments from drug & device makers

$1,493in general payments, 2019–2025

Across 90 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$458
  • Lilly USA, LLC$164
  • AstraZeneca$127
  • Pfizer$101
  • Johnson & Johnson$97
  • Boehringer Ingelheim$93
  • plus $454 from 15 others

What the payments were for

  • Food & beverage$1,493100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,493 in reported general payments places this provider in the 70th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$59,243
Medicare patients
289
Services billed
829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$48,673
TrulicityDulaglutide28$43,325
EliquisApixaban18$32,381
JardianceEmpagliflozin16$25,819
FarxigaDapagliflozin Propanediol14$19,780
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$16,139
MounjaroTirzepatide15$15,233
TradjentaLinagliptin14$10,782
SynthroidLevothyroxine Sodium42$3,240
Atorvastatin Calcium349$2,938
Potassium Chloride24$2,670
Levothyroxine Sodium183$1,756
Rosuvastatin Calcium138$1,737
Albuterol Sulfate HfaAlbuterol Sulfate30$1,570
Omeprazole82$1,355

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$164$58,55843 claims
Boehringer IngelheimJardiance, Tradjenta$93$36,60030 claims
PfizerEliquis$101$32,38118 claims
AstraZenecaFarxiga$127$19,78014 claims
AbbVieSynthroid$93$3,24042 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,084 family medicine providers in New Jersey.

Other family medicine in Ocean City

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →